{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:00:54Z","timestamp":1791320454247,"version":"4.3.1"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,7,3]],"date-time":"2002-07-03T00:00:00Z","timestamp":1025654400000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p> <jats:bold>BACKGROUND<\/jats:bold> : Transfusing only phenotype\u2010matched RBCs has been recommended to reduce the incidence of alloimmunization to blood group antigens in patients with sickle cell disease (SCD).<\/jats:p><jats:p> <jats:bold>STUDY DESIGN AND METHODS<\/jats:bold> : The expected benefit of phenotype matching was determined by identifying which of the existing blood group alloantibodies in patients with SCD who received conventional transfusions would not have been formed if they had received only phenotype\u2010matched RBCs. By use of each patient's alloantibodies as a baseline, it was possible to identify specific alloantibodies that would not have been formed if each of five different phenotype\u2010matching protocols had been used.<\/jats:p><jats:p> <jats:bold>RESULTS<\/jats:bold>\n          : During a 12\u2010year period, 351 patients received transfusions with 8939 units of ABO\u2010 and D\u2010matched RBCs. Of these, 102 patients (29.1%) formed at least one blood group alloantibody. An additional 35 patients with SCD with alloantibodies were identified by reviewing clinical records, yielding a total of 137 alloimmunized patients for inclusion in this study. If all transfusions had been selected by limited phenotype matching (C, c, E, e, and K, as well as for ABO and D), all alloantibodies would have been prevented for more than half (53.3%) of the 137 alloimmunized patients. If all transfusions had been matched for C, c, E, e, K, S, Fy\n          <jats:sup>a<\/jats:sup>\n          , and Jk\n          <jats:sup>b<\/jats:sup> , all antibodies would have been prevented for 70.8 percent of the 137 alloimmunized patients. Approximately 13.6 percent of random white blood donors would be expected to match a limited phenotype\u2010matching protocol, whereas only 0.6 percent would match an extended phenotype\u2010matching protocol.<\/jats:p><jats:p> <jats:bold>CONCLUSION<\/jats:bold> : Limited phenotype matching would have prevented all alloantibodies in 53.3 percent of the patients who formed alloantibodies. This protocol requires RBCs that are readily available. Extended phenotype matching would have prevented alloimmunization in 70.8 percent of patients who formed alloantibodies. However, this would require phenotypes that are 22.7 times less prevalent among random blood donors and is therefore impractical for a long\u2010term strategy.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2002.00126.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:49:48Z","timestamp":1047509388000},"page":"684-690","source":"Crossref","is-referenced-by-count":182,"title":["Predicting the effect of transfusing only phenotype\u2010matched RBCs to patients with sickle cell disease: theoretical and practical implications"],"prefix":"10.1111","volume":"42","author":[{"given":"Oswaldo","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u2003Gerald","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Houston\u2010Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1984.tb01587.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb05546.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.","volume":"76","author":"Rosse WF","year":"1990","journal-title":"Blood"},{"key":"e_1_2_5_5_2","unstructured":"Rosse WF Telen M Ware RE. Transfusion support for patients with sickle cell disease. Bethesda: AABB Press; 1998."},{"key":"e_1_2_5_6_2","first-page":"1421","article-title":"Transfusion of racially unmatched blood [letter].","volume":"323","author":"Heard SE","year":"1990","journal-title":"N Engl J Med"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830050204"},{"key":"e_1_2_5_8_2","first-page":"97","article-title":"Chronic transfusion regimens in sickle cell disease.","volume":"98","author":"Milner PF","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330402"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006073222301"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27187121485.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34794330008.x"},{"key":"e_1_2_5_13_2","unstructured":"Vengelen\u2010Tyler V editor. Technical Manual. 13th ed. Bethesda: AABB Press; 1999."},{"key":"e_1_2_5_14_2","unstructured":"Reid ME Lomas\u2010Francis C. The blood group antigen facts book. San Diego CA: Academic Press; 1997. p. 11 12 98."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26386209381.x"},{"key":"e_1_2_5_16_2","first-page":"314","article-title":"Variability in rates of alloimmunization in different groups of children with sickle cell disease: the effect of ethnic background.","volume":"11","author":"Luban NL","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199610000-00005"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/108.6.658"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380110115024"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198908000-00025"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-2-231"},{"key":"e_1_2_5_22_2","first-page":"13","article-title":"A delayed hemolytic transfusion reaction after partial exchange\u2010transfusion for sickle cell disease in pregnancy: a case report and review of the literature.","volume":"63","author":"Brumfield CG","year":"1984","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198512000-00016"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37497265337.x"},{"key":"e_1_2_5_25_2","first-page":"214","article-title":"Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.","volume":"16","author":"Mintz PD","year":"1986","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb00373.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1982.tb04645.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26587020111.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37497265339.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40070828.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422502"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.5.1109.bloodjournal8151109"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2002.00126.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2002.00126.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:10:57Z","timestamp":1697224257000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2002.00126.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1046\/j.1537-2995.2002.00126.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2002.00126.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}